retatrutide portugal Retatrutide Mechanism, Clinical Results and

But if a patient taking these drugs experiences vision loss, they should call their internist about possibly adjusting the dosage or stopping the medication

It also examined quality of life outcomes

Weiying Lu, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Nevertheless, Neeland and his colleagues concluded that the available evidence suggests that the proportion of lean and muscle mass people lose while taking GLP-1s is in line with the proportion that people lose through diet and exercise alone, but called for additional research to confirm

44 , D463D470 (2016)

Recent studies have also explored the ocular risks associated with GLP-1 therapies